Pliant Therapeutics paused BEACON-IPF trial for idiopathic pulmonary fibrosis, reviewing data per DSMB recommendation
From GlobeNewswire: 2025-02-07 16:58:09 Pliant Therapeutics, Inc. has paused enrollment and dosing in the BEACON-IPF Phase 2b trial for idiopathic
